2019 Immunisation for All Ages Summit
Executive Summary
“Prioritisation of Prevention,” the theme of the 2019 Immunisation for All Ages Summit, grounded the gathering in a solid understanding of the current global policy environment regarding the health, social and economic benefits of vaccines while also acknowledging the serious inequities within and across countries relating to optimal use of vaccines throughout each stage of life.
Experts and thought leaders from regional and global organizations, patient and advocacy organizations and academia came together with the purpose of strengthening the dialogue around a life course approach to vaccination as part of a broader public health promotion and prevention strategy.
[ms_document url=”https://www.vaccines4life.com/wp-content/uploads/2019/10/IFAA-Executive-Summary-and-Highlights.pdf” width=”900″ height=”1200″ responsive=”yes” viewer=”google” class=”” id=””][/ms_document]
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.